David H. Ilson, MD, PhD
Memorial Sloan Kettering Cancer Center
Professor of Medicine
Weill Cornell Medical College
New York, NY
0.5 AMA PRA Category 1 Credit™
Mobile + Online on Univadis
An estimated 26,370 Americans will be diagnosed with gastric cancer in 2016. Most patients with gastric cancer present with advanced or metastatic disease, for which the prognosis is poor. The 5-year survival rate of patients with all stages of gastric cancer in the United States is approximately 29% and drops into the single digits for patients with stage III or IV disease. However, recent advances and recently updated clinical practice guidelines are changing standards of care. This activity will address the state-of-the-art management of advanced gastric cancer.
This educational activity is designed to meet the needs of medical oncologists, oncology nurses and other clinicians involved in the treatment of patients with gastric cancer.
Upon completion of this educational activity, the participant should be able to:
- Explain current evidence for the role of palliative chemotherapy to improve survival and quality of life.
- Select therapeutic targets, including HER2 and VEGFR-2, and recommend appropriate regimens directed against these targets using current standards of care.
- Describe efficacy and safety data on investigational therapies to counsel patients about clinical trial enrollment.
Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
David H. Ilson, MD, PhD, discloses the following conflicts of interest.
Consultant: Pieris, Bristol Myers Squibb, Astra-Zeneca, Genentech, Lilly, Merck, Amgen, Astellas
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Lindsay Borvansky: Nothing to disclose
Karen Kaufman: Nothing to disclose
Lindsay Knight: Nothing to disclose
Lillian McVey: Nothing to disclose
Kathleen Hines: Nothing to disclose
Terry Glauser, MD: Nothing to disclose
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global and MCM Education do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and MCM Education. Global is accredited by the ACCME to provide continuing medical education for physicians.
Global Education Group designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
For information about the accreditation of this program, please contact Global at 303-395-1782 or firstname.lastname@example.org. This activity is jointly provided by Global Education Group and MCM Education.
Commercial Support Statements
This activity is supported by an independent educational grant from Lilly, USA.
- Accessing Activity:
* Click "Start Program" and log into program on QuantiaMD.com
* Take the pre-test
* Review the activity
* Take the post-test and score 80%
* You are allowed a total of 3 attempts
* Complete the evaluation
* View, print, or save a CME certificate verifying your
credit/participation in this activity
- Computer Requirements: Minimum System Requirements: • Pentium III, 600 MHz or Equivalent Processor • 512 MB of RAM • Windows XP, Vista, or 7 • Mac OS X • 800x600 Monitor Resolution • 16-bit Color • 16 bit Sound Card with Speakers
There is no charge for CME credit.
©2017 MCM Education. All rights reserved. None of the contents may be reproduced in any form without prior written permission from the publisher. The opinions expressed in this educational activity are those of the faculty and do not necessarily reflect the opinions or recommendations of their affiliated institutions, the publisher, Global Education Group, or Lilly, USA. Any medications, diagnostic procedures, or treatments discussed by the faculty should not be used by clinicians or other health care professionals without first evaluating their patients’ conditions, considering possible contraindications or risks, reviewing any applicable manufacturer’s product information, and comparing any therapeutic approach with the recommendations of other authorities.